← ANALYST RATINGS · TIPRANKS
GE Healthcare Technologies Inc (GEHC): analyst forecast and price target
Analyst consensus
Moderate Buy11 Buy5 Hold0 Sell
Ratings of 16 analysts in the last 3 months12-month forecast
Based on 16 price targets given in the last 3 months, the average target is $79.81, the highest $93.00, the lowest $70.00. The average is +14.7% from the last price of $69.57.
Analyst ratings 25
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $79.00 → $75.00−5.1% | Buy | +7.8% | Reiterated | 12.10.26on TipRanks 08:40 | +3.1%next day +1.6% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $85.00 | Buy | +22.2% | Initiated | 07.10.26on TipRanks 03:55 | +0.1%next day −0.3% · 5 days +6.9% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $79.00 | Buy | +13.6% | Reiterated | 05.10.26on TipRanks Oct 6 05:55 | +1.6%next day −2.0% · 5 days +2.6% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $93.00 | Buy | +33.7% | Reiterated | 05.10.26on TipRanks 10:45 | +1.6%next day −2.0% · 5 days +2.6% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $75.00 → $71.00−5.3% | Hold | +2.1% | Reiterated | 05.10.26on TipRanks 07:07 | +1.6%next day −2.0% · 5 days +2.6% | ↗ |
| Name not given | — | $80.00 | Buy | +15.0% | Reiterated | 01.10.26on TipRanks Oct 2 21:45 | −2.3%next day −0.3% · 5 days −0.9% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $71.00 → $70.00−1.4% | Hold | +0.6% | Downgrade | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $69.00 → $66.00−4.3% | Hold | −5.1% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $70.00 → $68.00−2.9% | Hold | −2.3% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $68.00 → $67.00−1.5% | Hold | −3.7% | Reiterated | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $71.00 → $69.00−2.8% | Hold | −0.8% | Downgrade | 23.09.26on TipRanks Sep 22 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $72.00 → $70.00−2.8% | Hold | +0.6% | Downgrade | 23.09.26on TipRanks Sep 22 23:05 | — | |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $93.00 | Buy | +33.7% | Initiated | 22.09.26on TipRanks 06:40 | +2.3%next day +0.4% · 5 days +1.5% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $74.00 | Hold | +6.4% | Reiterated | 14.09.26on TipRanks 06:25 | +0.9%next day +0.2% · 5 days −1.0% | ↗ |
| Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% | BMO Capital | $71.00 | Hold | +2.1% | Reiterated | 13.09.26on TipRanks Sep 14 10:45 | +0.9%next day +0.2% · 5 days −1.0% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $85.00 | Buy | +22.2% | Assigned | 25.08.26on TipRanks 06:30 | −0.7%next day −0.8% · 5 days −4.2% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | $79.00 | Buy | +13.6% | Reiterated | 19.08.26on TipRanks Aug 20 06:09 | +2.5%next day +0.1% · 5 days −1.4% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $75.00 | Hold | +7.8% | Reiterated | 13.08.26on TipRanks 06:55 | +1.4%next day +0.1% · 5 days +2.3% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $85.00 | Buy | +22.2% | Reiterated | 31.07.26on TipRanks Aug 4 08:19 | −3.5%next day +1.1% · 5 days +2.0% | ↗ |
| Graham Doyle★★★★★★★★★★#10650 · hits 47% · avg −2.2% | UBS | $67.00 → $73.00+9.0% | Hold | +4.9% | Assigned | 31.07.26on TipRanks 08:01 | −3.5%next day +1.1% · 5 days +2.0% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $65.00 → $70.00+7.7% | Hold | +0.6% | Assigned | 30.07.26on TipRanks 09:30 | −4.4%next day −3.5% · 5 days −3.1% | ↗ |
| Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% | Stifel Nicolaus | $80.00 | Buy | +15.0% | Reiterated | 30.07.26on TipRanks 09:05 | −4.4%next day −3.5% · 5 days −3.1% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $80.00 → $84.00+5.0% | Buy | +20.7% | Reiterated | 30.07.26on TipRanks 08:50 | −4.4%next day −3.5% · 5 days −3.1% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | $85.00 | Buy | +22.2% | Reiterated | 30.07.26on TipRanks 08:35 | −4.4%next day −3.5% · 5 days −3.1% | ↗ |
| Matthew Taylor★★★★★★★★★★#1367 · hits 55% · avg +7.2% | Jefferies | $90.00 → $92.00+2.2% | Buy | +32.2% | Reiterated | 30.07.26on TipRanks 08:30 | −4.4%next day −3.5% · 5 days −3.1% | ↗ |
| Name not given | — | $80.00 | Buy | +15.0% | Reiterated | 29.07.26on TipRanks Jul 30 07:02 | +13.7%next day −4.4% · 5 days −7.8% | ↗ |
| Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% | Piper Sandler | $74.00 | Buy | +6.4% | Reiterated | 24.07.26on TipRanks 08:16 | −2.3%next day +0.9% · 5 days +11.2% | ↗ |
| David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% | Goldman Sachs | — | Hold | — | Downgrade | 30.04.26on TipRanks 06:07 | +1.3%next day 0.0% · 5 days −1.0% | ↗ |
| Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% | Barclays | $87.00 → $78.00−10.3% | Hold | +12.1% | Reiterated | 30.04.26on TipRanks 04:55 | +1.3%next day 0.0% · 5 days −1.0% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | $95.00 | Buy | +36.6% | Assigned | 03.03.26on TipRanks Mar 4 09:35 | −1.7%next day +0.4% · 5 days −6.4% | ↗ |
| Nico Chen★★★★★★★★★★#2913 · hits 59% · avg +9.8% | DBS | $100 | Buy | +43.7% | Reiterated | 28.01.26on TipRanks 04:00 | −1.3%next day −0.4% · 5 days +5.6% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering GE Healthcare Technologies Inc
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $80.00 at a price of $65.37 (+22.4%); now: $79.81 at $69.57 (+14.7%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 14 | 13 | 20 | 22 | 21 | 8 |
| Hold | 9 | 7 | 10 | 11 | 12 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 28.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.21 (from $1.18 to $1.25). Last quarter: $1.13.
Sales
Next quarter’s sales estimate — $5.4B (from $5.3B to $5.4B). Last quarter: $5.3B.
Best top-analyst consensus in the sector · Healthcare
About GE Healthcare Technologies Inc
- CEO: Peter J. Arduini
- Employees: 54,000
- 500 West Monroe Street, Chicago, IL, 60661, US
- www.gehealthcare.com
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – inje
Data from the stock’s TipRanks forecast page, read 23 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗